Grosset, D.G. (1992) What have drugs to offer the patient with acute stroke? British Journal of Clinical Pharmacology, 33(5), pp. 467-472. (doi: 10.1111/j.1365-2125.1992.tb04072.x) (PMID:1524958) (PMCID:PMC1381431)
Full text not currently available from Enlighten.
Abstract
1. Drug treatment for acute stroke is designed to salvage neuronal tissue, and to prevent complications of stroke, which are often non‐ neurological. This review addresses the areas of recent advance in treatment designed to reduce the size of the cerebral infarct. With the exception of cardiac‐source embolism, for which anticoagulation in the acute phase is sometimes considered, prevention of recurrent events is not discussed. 2. It is to be hoped that pharmaceutical developments will improve the current bleak picture in which there are no proven treatments for ischaemic stroke or intracerebral haemorrhage. To meet this challenge will require careful, controlled evaluation of treatment early after acute stroke in large scale clinical studies.
| Item Type: | Articles |
|---|---|
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Grosset, Professor Donald |
| Authors: | Grosset, D.G. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience |
| Journal Name: | British Journal of Clinical Pharmacology |
| Publisher: | Wiley |
| ISSN: | 0306-5251 |
| ISSN (Online): | 1365-2125 |
University Staff: Request a correction | Enlighten Editors: Update this record
Deposit and Record Details
Deposit and Record Details